Skip to main content
. 2023 Jan 6;9:994775. doi: 10.3389/fsurg.2022.994775

Table 3.

Comparison between different Age groups of patients in terms of general information.

  <35-year-old group P ≥35-year-old group P
Phloroglucinol group (n = 137) Control group (n = 139) Phloroglucinol group (n = 80) Control group (n = 97)
Age (years) 30.64 ± 2.51 30.41 ± 2.82 0.471 38.73 ± 2.77 38.64 ± 2.69 0.835
Infertility duration (years) 3.44 ± 2.00 3.25 ± 2.36 0.480 4.75 ± 3.04 4.80 ± 4.57 0.928
BMI (kg/m2) 21.49 ± 1.99 21.34 ± 2.17 0.555 22.45 ± 2.35 22.29 ± 2.27 0.644
Proportion of primary infertility 60.58 (83/137) 64.03 (89/139) 0.555 20 (16/80) 22.68 (22/97) 0.666
Proportion of secondary infertility 39.42 (54/137) 35.97 (50/139)   80 (64/80) 77.32 (75/97)  
Endometrial thickness on the day of embryo transfer (mm) 10.37 ± 2.00 10.02 ± 1.71 0.115 10.21 ± 2.02 9.84 ± 2.44 0.282
Mean number of transferred embryos 1.62 ± 0.49 1.63 ± 0.50 0.927 1.54 ± 0.50 1.54 ± 0.52 0.985
Mean number of high quality embryos 1.54 ± 0.50 1.51 ± 0.50 0.627 1.41 ± 0.50 1.45 ± 050 0.585
Developmental stage of the transferred embryos
Cleavage stage embryos 78.10 (107/137) 69.78 (97/139) 0.116 86.25 (69/80) 81.44 (79/97) 0.390
Branstocysts 21.90 (30/137) 30.22 (42/139)   13.75 (11/80) 18.56 (18/97)